Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Healthtrust
AstraZeneca
Fish and Richardson
Colorcon
Chubb
Argus Health
QuintilesIMS
Merck

Generated: August 22, 2017

DrugPatentWatch Database Preview

Paramethasone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for paramethasone acetate and what is the scope of paramethasone acetate freedom to operate?

Paramethasone acetate
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for paramethasone acetate.

Summary for Generic Name: paramethasone acetate

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Bulk Api Vendors: see list9
Clinical Trials: see list918
Patent Applications: see list1,887
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:paramethasone acetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
HALDRONE
paramethasone acetate
TABLET;ORAL012772-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
HALDRONE
paramethasone acetate
TABLET;ORAL012772-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: paramethasone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
HALDRONE
paramethasone acetate
TABLET;ORAL012772-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Lilly
HALDRONE
paramethasone acetate
TABLET;ORAL012772-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Healthtrust
AstraZeneca
Baxter
Cerilliant
Federal Trade Commission
Johnson and Johnson
Medtronic
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot